Mar 15, 2022 / 02:15PM GMT
Peter Richard Lawson - Barclays Bank PLC, Research Division - Research Analyst
Thank you so much. First and foremost, I'll probably be saying this for the rest of the day, but I just the fact that I was coming down to Miami, first in-person conference for 2 years, for Barclays, for Wall Street, et cetera. And my name is Peter Lawson, I'm going to be the moderator of this and was biotech analyst of Barclays doing (inaudible) oncology. And just wanted to thank Chris Senner, CFO; and Andrew Peters, SVP of Strategy, who also kind of made it across to Miami as well to do this in person.
And I guess the first question would be just, I guess, you're going to do an overview when we touch upon the differentiation.
Christopher J. Senner - Exelixis, Inc. - Executive VP & CFO
Yes, just like to say, thanks for having us. It's been -- like you said, it's been 2 years, last in-person conference we did was Cowen 2020. So thank you for having us. And really appreciate the invitation. From a forward-looking perspective, during the course of the conversation, this
Exelixis Inc at Barclays Global Healthcare Conference Transcript
Mar 15, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers